Catheter ablation for atrial fibrillation in a subset of patients with concomitant hypertension

doi:10.5494/wjh.v5.i2.98

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5751)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

344

WORD

276

HTML

2471

Figures (1-1)

182

Tables (1-2)

173

Sum=3446

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1004

Download

1301

Sum=2305

May 23, 2015 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hypertens. May 23, 2015; 5(2): 98-103
Published online May 23, 2015. doi: 10.5494/wjh.v5.i2.98

Table 1 Anti-hypertensive drugs taken by patients before and after catheter ablation procedures

No. of patients	Anti-hypertensive agents
7	ACE inhibitor
7	Calcium channel blockers
2	Beta blockers
1	Angiotensin 2 receptor blocker
6	ACE inhibitor, beta blocker
3	Calcium channel blocker, angiotensin 2 receptor blocker
2	ACE inhibitor blocker. Calcium channel blocker
2	ACE inhibitor, diuretic
1	Calcium channel blocker, beta blocker, diuretic
1	Calcium channel blocker, beta blocker
1	ACE inhibitor, calcium channel blocker, diuretic

Table 2 Comparison of descriptive statistics between Study Groups

Variable	Group 1 (LAD ≤4 cm), mean ± SD	Group 2 (LAD > 4 cm), mean ± SD
AGE (yr)	58.3 ± 9.2	60.4 ± 6.8
LAD (cm)	3.63 ± 0.34	4.54 ± 0.4
Pre-ablation SBP (mmHg)	142.6 ± 13.7	130.3 ± 17.5
Pre-ablation DBP (mmHg)	83.8 ± 11.6	80.6 ± 15.6
SBP - 2 wk (mmHg)	126.8 ± 19.4^a	129.6 ± 16.9
DBP - 2 wk (mmHg)	76.2 ± 13.5	78.9 ± 11.5
SBP - 3 mo (mmHg)	129.1 ± 15.4^a	132.1 ± 13.6
DBP - 3 mo (mmHg)	77.6 ± 12.8	79.1 ± 12.2
SBP - 6 mo (mmHg)	123.7 ± 16.8^a^b	134.3 ± 14.4
DBP - 6 mo (mmHg)	76 ± 10.1	77.7 ± 9.5
SBP - 1 yr (mmHg)	119.2 ± 13^a^b	130.4 ± 13.4
DBP - 1 yr (mmHg)	70.4 ± 12.2	78.7 ± 9.1

Group 1: LAD ≤ 4.0 cm; Group 2: LAD > 4.0 cm;

^aP≤ 0.05 compared to SBP pre-ablation;

^bP = 0.008, P = 0.001, Group 1 SBP compared to Group 2 SBP at 6 mo and 1 year, respectively, after the GP and PVI ablation procedure. LAD: Left atrial dimension; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.

Citation: Sharma T, Scherlag BJ, Nakagawa H, Jackman WM, Lazzara R, Po SS. Catheter ablation for atrial fibrillation in a subset of patients with concomitant hypertension. World J Hypertens 2015; 5(2): 98-103
URL: https://www.wjgnet.com/2220-3168/full/v5/i2/98.htm
DOI: https://dx.doi.org/10.5494/wjh.v5.i2.98